EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aptamer-Based Gold Nanoparticle Lateral Flow Assay for Rapid Detection of Cardiac Troponin I

Jing Zhang, Jiayi Pang, Cheng Cui iD

Biosensors · 2025

DOI: 10.3390/bios15120776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2025. Verfasst von Jing Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Science and Medical Engineering, Hunan University of Technology, Zhuzhou 412007, China. Hauptthemen laut MEDLINE: Troponin I, Aptamers, Nucleotide, Gold, Metal Nanoparticles. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac troponin I (cTnI) is a critical biomarker for the diagnosis of acute myocardial infarction (AMI), but conventional detection methods are often time-consuming and require specialized laboratory equipment. To meet the need for rapid and feasible detection, there is an urgent demand for methods that are fast, specific, and easy to use. In this study, two aptamers (Tro4 and Tro6), which specifically bind to different epitopes of cTnI, were employed to construct a dual-aptamer sandwich system on a lateral flow assay (LFA) strip. The test strip can deliver results within 10 min and shows a detection limit of 11.70 ng·mL−1. It also exhibited excellent stability after storage at room temperature for up to four months. The assay demonstrated high analytical accuracy, as evidenced by recovery rates from spiked serum samples ranging from 95.11% to 103.17%. These results suggest that the proposed aptamer-based LFA is highly suitable for rapid screening of cTnI, especially in point-of-care settings and resource-limited environments. From a diagnostic perspective, this method holds great promise for improving the timely detection and management of AMI and other myocardial injuries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin IAptamers, NucleotideGoldMetal NanoparticlesBiosensing TechniquesHumansLimit of DetectionMyocardial Infarction

Stichwörter der Autor:innen

acute myocardial infarctionaptamercTnIgold nanoparticlelateral flowrapid detectionsandwich

Substanzen

Troponin IAptamers, NucleotideGold

Autor:innen und Institutionen

  • School of Biological Science and Medical Engineering, Hunan University of Technology, Zhuzhou 412007, China.
  • Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan Un…

ORCID-Profile: Cheng Cui

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhang, J., Pang, J., & Cui, C. (2025). Aptamer-Based Gold Nanoparticle Lateral Flow Assay for Rapid Detection of Cardiac Troponin I. Biosensors. https://doi.org/10.3390/bios15120776

Vancouver

Zhang J, Pang J, Cui C. Aptamer-Based Gold Nanoparticle Lateral Flow Assay for Rapid Detection of Cardiac Troponin I. Biosensors. 2025. doi:10.3390/bios15120776

BibTeX
@article{Zhang2025,
  author = {Zhang, Jing and Pang, Jiayi and Cui, Cheng},
  title = {Aptamer-Based Gold Nanoparticle Lateral Flow Assay for Rapid Detection of Cardiac Troponin I},
  journal = {Biosensors},
  year = {2025},
  doi = {10.3390/bios15120776}
}
Kostenlos starten →